The role of patient advocacy networks at the EBCC

Susan Knox - Executive Director of Europa Donna, Milan, Italy
The role of patient advocacy networks at the EBCC ( Susan Knox - Executive Director of Europa Donna, Milan, Italy )
1 Apr 2014

Diagnostic and treatment resources must be transferred from developed to developing nations

Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Diagnostic and treatment resources must be transferred from developed to developing nations ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
1 Apr 2014

Systematic and homogenous approach needed for the treatment of breast cancer patients

Prof Elizabeth Charlotte Moser - Champalimaud Cancer Center, Lisbon, Portugal
Systematic and homogenous approach needed for the treatment of breast cancer patients ( Prof Elizabeth Charlotte Moser - Champalimaud Cancer Center, Lisbon, Portugal )
1 Apr 2014

Consensus on the treatment of breast cancer and early intervention using endocrine therapy

Prof Nadia Harbeck - University of Munich, Munich, Germany
Consensus on the treatment of breast cancer and early intervention using endocrine therapy ( Prof Nadia Harbeck - University of Munich, Munich, Germany )
1 Apr 2014

Deaths from breast cancer fall in Europe, but unexplained differences between countries remain

Dr Philippe Autier - International Prevention Research Institute, Lyon, France
Deaths from breast cancer fall in Europe, but unexplained differences between countries remain ( Dr Philippe Autier - International Prevention Research Institute, Lyon, France )
1 Apr 2014

Breast cancer screening in the UK: does it work?

Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK
Breast cancer screening in the UK: does it work? ( Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK )
1 Apr 2014

Significant UK variations between hospitals in adverse outcomes for DCIS

Dr Jeremy Thomas - Western General Hospital, Edinburgh, UK
Significant UK variations between hospitals in adverse outcomes for DCIS ( Dr Jeremy Thomas - Western General Hospital, Edinburgh, UK )
1 Apr 2014

EBCC 2014 key messages to doctors

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
EBCC 2014 key messages to doctors ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014

mCRPC management in Taiwan - expert interview

Prof Paul de Souza and Dr Wayne Yen-Hwa Chang
mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )
21 Mar 2014

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014

Multiple Myeloma Debate 2014: Recent advances in multiple myeloma

Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014

ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases

Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases ( Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden )
1 Feb 2014